Le Lézard2h
U.S. FDA Approves Pfizer's ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...
Stevens Institute of Technology11h
Graduate Events and Open Houses
Graduate Admissions holds open houses and networking events throughout the year to help you learn firsthand how studying at Stevens gives you a competitive advantage. You'll meet with our ...